Niki BioSolutions, Inc. - Common Stock (NIKI)

5.8400
+0.1300 (2.28%)
NASDAQ· Last Trade: Sep 14th, 6:25 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics
Advanced multi-omics data analysis and biostatistical expertise to sharpen target and biomarker decisions across the platform
By Niki BioSolutions, Inc. · Via GlobeNewswire · September 14, 2026
Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
Live company presentation will take place on September 14 at 10:30 AM ET
By Niki BioSolutions, Inc. · Via GlobeNewswire · September 8, 2026
Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)
Partnership Expands Access to Clinically Critical Genetic Testing in Support of Leading Research Programs
By Niki BioSolutions, Inc. · Via GlobeNewswire · July 23, 2026